PATENT CLAIM ANALYSIS

Application Number: 16104224
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["435", "325000"]

Abstract:
Objects of the present invention are to provide a method for directly obtaining pluripotent stern cells which do not have tumorigenic property from body tissue and the thus obtained pluripotent stem cells. The present invention relates to SSEA-3 (+) pluripotent stern cells that can be isolated from body tissue.

Claim (Index 9):
The cell fraction of  claim 5  wherein at least the expression of the CD34 and CD117 cell markers is not observed.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 96.0
- Lexical Diversity: 1.325
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13435703', '12836264', '15802899', '14421754', '15413129']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7032962412663973
- 35 USC 102 Novelty (BERT): 0.5888181228304887
- Combined Prediction Score: 0.6918484294228066
- Mean Citation Score: 454.151506
- Max Citation Score: 643.65594
- Similarity Product: 400.4848821586132

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test